179 related articles for article (PubMed ID: 15213292)
1. The structural basis for GTS-21 selectivity between human and rat nicotinic alpha7 receptors.
Stokes C; Papke JK; Horenstein NA; Kem WR; McCormack TJ; Papke RL
Mol Pharmacol; 2004 Jul; 66(1):14-24. PubMed ID: 15213292
[TBL] [Abstract][Full Text] [Related]
2. Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.
Meyer EM; Kuryatov A; Gerzanich V; Lindstrom J; Papke RL
J Pharmacol Exp Ther; 1998 Dec; 287(3):918-25. PubMed ID: 9864273
[TBL] [Abstract][Full Text] [Related]
3. Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist.
Papke RL; Schiff HC; Jack BA; Horenstein NA
Neurosci Lett; 2005 Apr; 378(3):140-4. PubMed ID: 15781147
[TBL] [Abstract][Full Text] [Related]
4. Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration.
Kem WR; Mahnir VM; Prokai L; Papke RL; Cao X; LeFrancois S; Wildeboer K; Prokai-Tatrai K; Porter-Papke J; Soti F
Mol Pharmacol; 2004 Jan; 65(1):56-67. PubMed ID: 14722237
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.
Papke RL; Porter Papke JK
Br J Pharmacol; 2002 Sep; 137(1):49-61. PubMed ID: 12183330
[TBL] [Abstract][Full Text] [Related]
6. Reversal of agonist selectivity by mutations of conserved amino acids in the binding site of nicotinic acetylcholine receptors.
Horenstein NA; McCormack TJ; Stokes C; Ren K; Papke RL
J Biol Chem; 2007 Feb; 282(8):5899-909. PubMed ID: 17189260
[TBL] [Abstract][Full Text] [Related]
7. Effects at a distance in alpha 7 nAChR selective agonists: benzylidene substitutions that regulate potency and efficacy.
Papke RL; Meyer EM; Lavieri S; Bollampally SR; Papke TA; Horenstein NA; Itoh Y; Porter Papke JK
Neuropharmacology; 2004 Jun; 46(7):1023-38. PubMed ID: 15081799
[TBL] [Abstract][Full Text] [Related]
8. Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine(3A) receptor.
Machu TK; Hamilton ME; Frye TF; Shanklin CL; Harris MC; Sun H; Tenner TE; Soti FS; Kem WR
J Pharmacol Exp Ther; 2001 Dec; 299(3):1112-9. PubMed ID: 11714901
[TBL] [Abstract][Full Text] [Related]
9. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.
Kem WR; Mahnir VM; Papke RL; Lingle CJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):979-92. PubMed ID: 9399967
[TBL] [Abstract][Full Text] [Related]
10. alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation.
Ren K; Thinschmidt J; Liu J; Ai L; Papke RL; King MA; Hughes JA; Meyer EM
Neuroscience; 2007 Mar; 145(1):314-22. PubMed ID: 17218065
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel α7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs.
Kombo DC; Mazurov AA; Chewning J; Hammond PS; Tallapragada K; Hauser TA; Speake J; Yohannes D; Caldwell WS
Bioorg Med Chem Lett; 2012 Jan; 22(2):1179-86. PubMed ID: 22177081
[TBL] [Abstract][Full Text] [Related]
12. The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.
Ren K; King MA; Liu J; Siemann J; Altman M; Meyers C; Hughes JA; Meyer EM
Neuroscience; 2007 Aug; 148(1):230-7. PubMed ID: 17640819
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of receptor activation and agonist selectivity by highly conserved tryptophans in the nicotinic acetylcholine receptor binding site.
Williams DK; Stokes C; Horenstein NA; Papke RL
J Pharmacol Exp Ther; 2009 Jul; 330(1):40-53. PubMed ID: 19339660
[TBL] [Abstract][Full Text] [Related]
14. N-terminal domains in mouse and human 5-hydroxytryptamine3A receptors confer partial agonist and antagonist properties to benzylidene analogs of anabaseine.
Zhang R; White NA; Soti FS; Kem WR; Machu TK
J Pharmacol Exp Ther; 2006 Jun; 317(3):1276-84. PubMed ID: 16551836
[TBL] [Abstract][Full Text] [Related]
15. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.
Pavlov VA; Ochani M; Yang LH; Gallowitsch-Puerta M; Ochani K; Lin X; Levi J; Parrish WR; Rosas-Ballina M; Czura CJ; Larosa GJ; Miller EJ; Tracey KJ; Al-Abed Y
Crit Care Med; 2007 Apr; 35(4):1139-44. PubMed ID: 17334244
[TBL] [Abstract][Full Text] [Related]
16. Activation and desensitization of nicotinic alpha7-type acetylcholine receptors by benzylidene anabaseines and nicotine.
Papke RL; Kem WR; Soti F; López-Hernández GY; Horenstein NA
J Pharmacol Exp Ther; 2009 May; 329(2):791-807. PubMed ID: 19223664
[TBL] [Abstract][Full Text] [Related]
17. alpha7 receptor-selective agonists and modes of alpha7 receptor activation.
Papke RL; Meyer E; Nutter T; Uteshev VV
Eur J Pharmacol; 2000 Mar; 393(1-3):179-95. PubMed ID: 10771012
[TBL] [Abstract][Full Text] [Related]
18. GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation.
Kox M; van Velzen JF; Pompe JC; Hoedemaekers CW; van der Hoeven JG; Pickkers P
Biochem Pharmacol; 2009 Oct; 78(7):863-72. PubMed ID: 19576181
[TBL] [Abstract][Full Text] [Related]
19. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
Mihalak KB; Carroll FI; Luetje CW
Mol Pharmacol; 2006 Sep; 70(3):801-5. PubMed ID: 16766716
[TBL] [Abstract][Full Text] [Related]
20. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
Qi XL; Nordberg A; Xiu J; Guan ZZ
Neurochem Int; 2007; 51(6-7):377-83. PubMed ID: 17493709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
